Table 4.

Cox proportional hazard models for risk of death with treatment by an adult versus pediatric oncology provider among 9,993 AYAs 15 to 24 years old.

	aHR (95% CI)	P
Entire cohorta	1.00 (0.86–1.18)	0.98
Lymphoma	0.69 (0.48–0.99)	0.04
Hodgkin lymphoma	0.99 (0.53–1.83)	0.97
Non–Hodgkin lymphoma	0.61 (0.39–0.96)	0.03
Extracranial GCT	1.57 (0.82–3.00)	0.17
Sarcoma	1.01 (0.80–1.29)	0.91
Osteosarcoma	0.92 (0.60–1.41)	0.69
Ewing sarcoma	1.20 (0.74–1.94)	0.46
Rhabdomyosarcoma	2.22 (1.03–4.76)	0.04
Leukemia	0.94 (0.73–1.20)	0.60
ALL	1.19 (0.88–1.59)	0.25
AML	0.77 (0.51–1.15)	0.19
CNS malignancy	1.63 (1.12–2.37)	0.01
Carcinoma	0.66 (0.39–1.11)	0.12

^aExcludes patients with a diagnosis of leukemia; see Methods.